Biblio
CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting. J Hematol Oncol. 2023;16(1):18.
. Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing. Nat Commun. 2024;15(1):1405.